Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic

SFA Rizvi, L Zhang, H Zhang… - ACS Pharmacology & …, 2024 - ACS Publications
The emergence of peptide–drug conjugates (PDCs) that utilize target-oriented peptide
moieties as carriers of cytotoxic payloads, interconnected with various cleavable …

New drug delivery strategies targeting the GnRH receptor in breast and other cancers

HSA Ghaly, P Varamini - Endocrine-Related Cancer, 2021 - erc.bioscientifica.com
Cancer is the uncontrolled division of abnormal cells in a specific organ. Globally, about one
in six deaths is due to cancer. Despite the plethora of research being undertaken worldwide …

[HTML][HTML] BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy

R Chilamakuri, DC Rouse, Y Yu, AS Kabir, A Muth… - Translational …, 2022 - Elsevier
High-risk neuroblastoma (NB) represents a major clinical challenge in pediatric oncology
due to relapse of metastatic, drug-resistant disease, and treatment-related toxicities. An …

miR-29a/b1 Regulates the Luteinizing Hormone Secretion and Affects Mouse Ovulation

Y Guo, Y Wu, J Shi, H Zhuang, L Ci, Q Huang… - Frontiers in …, 2021 - frontiersin.org
miR-29a/b1 was reportedly involved in the regulation of the reproductive function in female
mice, but the underlying molecular mechanisms are not clear. In this study, female mice …

Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

SFA Rizvi, H Zhang, Q Fang - Medicinal Research Reviews, 2024 - Wiley Online Library
The development of peptide drugs has made tremendous progress in the past few decades
because of the advancements in modification chemistry and analytical technologies. The …

Recent Progress in the Development of Peptide-Drug Conjugates (PDCs) for Cancer Therapy

H He, X Deng, Z Wang, J Chen - European Journal of Medicinal Chemistry, 2024 - Elsevier
Peptide-drug conjugates (PDCs) are emerging therapeutic agents composed of peptides,
linkers, and payloads, which possess favorable targeting capability and can deliver enough …

Discovery of the thieno [2, 3-d] pyrimidine-2, 4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist

F Zou, Y Wang, D Yu, C Liu, J Lu, M Zhao, M Ma… - European Journal of …, 2022 - Elsevier
The gonadotropin releasing hormone receptor (GnRH-R) is a G protein-coupled receptor
(GPCR) belonging to the rhodopsin family. GnRH-R antagonists suppress testosterone to …

Optimizing anticancer pharmacotherapy in kidney disease: Estimation of kidney function and evaluation of heterogeneous kinase inhibitor pharmacokinetics

MA Butrovich - 2024 - d-scholarship.pitt.edu
Kidney disease is common in cancer patients, with almost 20% of all solid tumor patients
having an estimated glomerular filtration rate (GFR; eGFR)< 60 mL/min. Kidney function is …

[PDF][PDF] I-es típusú luteinizáló hormon-releasing hormon receptor alapú új terápiás lehetőségek és a tumor angiogenezisének vizsgálata magas mortalitású daganatok …

MF Klára - dea.lib.unideb.hu
FBS: borjú szérum albumin FSH: follikulus stimuláló hormon FZD6: frizzled class receptor 6
GAPDH: glicerinaldhehid-3-foszfát dehidrogenáz GHRH: növekedési hormon-releasing …

[PDF][PDF] Az ELTE'SzintPlusz'Tématerületi Kiválósági Program első éve: 2019-2020

A Perczel - MAGYAR KÉMIAI FOLYÓIRAT-KÉMIAI …, 2021 - real.mtak.hu
A programozott sejthalál, és ennek egyik fontos formája, az apoptózis a veszélyt jelentő
sejtek eltávolításának egyik fontos útvonala. 1 Az apoptózis elkerülése a rák kifejlődésének …